REQUEST A DEMO
Total
USD $0.00
Search more companies

Drogueria Inti S.A. (Bolivia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Drogueria Inti S.A. Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Drogueria Inti S.A is a company that operates in the pharmaceutical industry of Bolivia. Currently, it’s the biggest and most important player in the sector. Its mission is to protect people’s health by producing different types of medicines. Inti got awarded a Good Manufacturing Practices certificate by the Ministry of Health and Sport of Bolivia.

Headquarters
Calle Lucas Jaimes N 1959
La Paz; La Paz;

Contact Details: Purchase the Drogueria Inti S.A. report to view the information.

Website: http://www.inti.com.bo

Basic Information
Total Employees:
Purchase the Drogueria Inti S.A. report to view the information.
Outstanding Shares:
Purchase the Drogueria Inti S.A. report to view the information.
Registered Capital:
Purchase the Drogueria Inti S.A. report to view the information.
Financial Auditors:
Purchase the Drogueria Inti S.A. report to view the information.
Incorporation Date:
1947
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Financial and Administrative Manager
Ownership Details
Purchase this report to view the information.
26.45%
Purchase this report to view the information.
22.23%
Purchase this report to view the information.
21.82%
Purchase this report to view the information.
9.46%
Purchase this report to view the information.
8.99%
Company Performance
Financial values in the chart are available after Drogueria Inti S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BOB. Absolute financial data is included in the purchased report.
Net sales revenue
7.07%
Total operating revenue
7.04%
Operating profit (EBIT)
29.24%
Net Profit (Loss) for the Period
1.31%
Total assets
5.88%
Total equity
4.92%
Operating Profit Margin (ROS)
1.92%
Net Profit Margin
-0.37%
Return on Equity (ROE)
-0.22%
Debt to Equity Ratio
-9.32%
Quick Ratio
0%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?